Medivie Therapeutic Financials
| MDVI Stock | ILA 83.40 0.10 0.12% |
Medivie |
Understanding current and past Medivie Therapeutic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medivie Therapeutic's financial statements are interrelated, with each one affecting the others. For example, an increase in Medivie Therapeutic's assets may result in an increase in income on the income statement.
The data published in Medivie Therapeutic's official financial statements usually reflect Medivie Therapeutic's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medivie Therapeutic. For example, before you start analyzing numbers published by Medivie accountants, it's critical to develop an understanding of what Medivie Therapeutic's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Medivie Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medivie Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medivie Therapeutic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medivie Therapeutic. Please utilize our Beneish M Score to check the likelihood of Medivie Therapeutic's management manipulating its earnings.
Medivie Therapeutic Stock Summary
Medivie Therapeutic competes with IDI Insurance, Bezeq Israeli, YH Dimri, Seach Medical, and Migdal Insurance. Medivie Therapeutic Limited develops and markets dental devices. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. MEDIVIE THERP is traded on Tel Aviv Stock Exchange in Israel.| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011226540 |
| Business Address | 1 The Willows, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | NYSE Composite |
| Website | www.medivie.com |
| Phone | 44 8708 200 096 |
| Currency | ILA |
You should never invest in Medivie Therapeutic without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medivie Stock, because this is throwing your money away. Analyzing the key information contained in Medivie Therapeutic's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medivie Therapeutic Key Financial Ratios
Generally speaking, Medivie Therapeutic's financial ratios allow both analysts and investors to convert raw data from Medivie Therapeutic's financial statements into concise, actionable information that can be used to evaluate the performance of Medivie Therapeutic over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medivie Therapeutic reports annually and quarterly.Medivie Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medivie Therapeutic's current stock value. Our valuation model uses many indicators to compare Medivie Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medivie Therapeutic competition to find correlations between indicators driving Medivie Therapeutic's intrinsic value. More Info.Medivie Therapeutic is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medivie Therapeutic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medivie Therapeutic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medivie Therapeutic's earnings, one of the primary drivers of an investment's value.Medivie Therapeutic Systematic Risk
Medivie Therapeutic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medivie Therapeutic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Medivie Therapeutic correlated with the market. If Beta is less than 0 Medivie Therapeutic generally moves in the opposite direction as compared to the market. If Medivie Therapeutic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medivie Therapeutic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medivie Therapeutic is generally in the same direction as the market. If Beta > 1 Medivie Therapeutic moves generally in the same direction as, but more than the movement of the benchmark.
About Medivie Therapeutic Financials
What exactly are Medivie Therapeutic Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Medivie Therapeutic's income statement, its balance sheet, and the statement of cash flows. Potential Medivie Therapeutic investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Medivie Therapeutic investors may use each financial statement separately, they are all related. The changes in Medivie Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medivie Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Medivie Therapeutic Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Medivie Therapeutic is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Medivie has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Medivie Therapeutic's financials are consistent with your investment objective using the following steps:- Review Medivie Therapeutic's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Medivie Therapeutic's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Medivie Therapeutic's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Medivie Therapeutic's stock is overvalued or undervalued.
Medivie Therapeutic April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medivie Therapeutic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medivie Therapeutic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medivie Therapeutic based on widely used predictive technical indicators. In general, we focus on analyzing Medivie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medivie Therapeutic's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.57 | |||
| Information Ratio | 0.0695 | |||
| Maximum Drawdown | 23.1 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 7.89 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medivie Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Medivie Stock analysis
When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |